AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 159 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 9.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,511,000 | -55.6% | 62,507 | -12.8% | 2.71% | -52.4% |
| Q1 2019 | $3,405,000 | +64.1% | 71,675 | +24.7% | 5.69% | -0.8% |
| Q4 2018 | $2,075,000 | -53.8% | 57,486 | -21.2% | 5.73% | +38.2% |
| Q3 2018 | $4,491,000 | +33.6% | 72,970 | +46.7% | 4.15% | +25.6% |
| Q2 2018 | $3,361,000 | -11.1% | 49,756 | -28.6% | 3.30% | -30.1% |
| Q1 2018 | $3,780,000 | +56.8% | 69,676 | +72.8% | 4.73% | +44.5% |
| Q4 2017 | $2,410,000 | +175.7% | 40,330 | +124.4% | 3.27% | +222.6% |
| Q3 2017 | $874,000 | -34.7% | 17,975 | -29.4% | 1.01% | -36.1% |
| Q2 2017 | $1,338,000 | -39.5% | 25,464 | -47.8% | 1.59% | -48.6% |
| Q1 2017 | $2,213,000 | -8.8% | 48,800 | -23.9% | 3.08% | -31.6% |
| Q4 2016 | $2,426,000 | -57.3% | 64,095 | -57.5% | 4.51% | -54.4% |
| Q3 2016 | $5,686,000 | +284.4% | 150,651 | +79.3% | 9.89% | +265.0% |
| Q2 2016 | $1,479,000 | -13.5% | 84,026 | -40.2% | 2.71% | -39.2% |
| Q1 2016 | $1,710,000 | -18.3% | 140,587 | +63.7% | 4.46% | +40.9% |
| Q4 2015 | $2,092,000 | +37.4% | 85,895 | +0.1% | 3.16% | -6.8% |
| Q3 2015 | $1,523,000 | – | 85,834 | – | 3.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |